ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nephrology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,416Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 42

$531K Total Retail Price of All Prescriptions

Rank: 9 out of 42

369 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
56% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 369 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

24% of this provider’s 369 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

2% of this provider’s 8,476 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
FUROSEMIDE 589 501 1 1
SIMVASTATIN 582 455 2 5
OMEPRAZOLE 424 315 3 6
POTASSIUM CHLORIDE 386 280 4 15
LISINOPRIL 380 314 5 3
HYDROCODONE-ACETAMINOPHEN 363 208 S3 6 17
CALCITRIOL 350 312 7 4
ATENOLOL 270 212 8 26
LEVOTHYROXINE SODIUM 263 169 9 8
AMLODIPINE BESYLATE 262 231 10 2
NABUMETONE 249 178 11 68
ISOSORBIDE MONONITRATE ER 224 183 12 33
LOSARTAN POTASSIUM 205 151 13 9
WARFARIN SODIUM 191 158 14 21
METOPROLOL TARTRATE 174 142 15 10
GLIPIZIDE 160 145 16 34
METFORMIN HCL 149 78 17 23
ALLOPURINOL 146 114 18 7
GLIMEPIRIDE 144 129 19 38
ATORVASTATIN CALCIUM 142 85 20 13
SPIRONOLACTONE 126 95 21 12
ZOLPIDEM TARTRATE 124 101 22 35
METOPROLOL SUCCINATE 121 102 23 18
CLOPIDOGREL 119 99 24 40
GEMFIBROZIL 97 27 25 49
FLUOXETINE HCL 96 58 26 64
TRAMADOL HCL 96 69 26 29
CARVEDILOL 89 57 28 11
TRIAMTERENE-HCTZ 88 68 29 83
GABAPENTIN 84 31 30 19
LEVEMIR 83 75 31 88
RANITIDINE HCL 82 55 32 63
ENALAPRIL MALEATE 79 63 33 42
PLAVIX 77 65 34 66
ALENDRONATE SODIUM 71 56 35 46
PROAIR HFA 67 39 36 76
FAMOTIDINE 66 35 37 69
PAROXETINE HCL 66 53 37 61
FENTANYL 65 50 S2 39 121
AMITRIPTYLINE HCL 62 33 R 40 56
ESCITALOPRAM OXALATE 61 45 41 123
CYCLOBENZAPRINE HCL 60 11 R 42 97
SERTRALINE HCL 60 29 42 50
DIGOXIN 55 51 44 86
JANUVIA 55 43 44 41
PEN NEEDLE 54 31 46 44
PREDNISONE 53 39 47 16
MIDODRINE HCL 52 32 48 48
RAMIPRIL 51 51 49 101
LEVOFLOXACIN 50 42 50 71
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 15, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.